NASDAQ:COSM Cosmos Health Q2 2026 Earnings Results & Report $0.35 +0.03 (+10.37%) As of 12:48 PM Eastern This is a fair market value price provided by Massive. Learn more. Cosmos Health met analyst earnings expectations and beat on revenue in its Q2 2026 results, released August 18, 2026. The company reported EPS of -$0.10 versus the -$0.10 consensus estimate, while revenue of $19.32 million topped the $18.99 million estimate by $0.33 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 18, 2026TimeBefore Market Opens Cosmos Health EPS ResultsActual EPS-$0.10Consensus EPS -$0.10Beat/MissMet ExpectationsOne Year Ago EPSN/AEPS Beat Rate2 of last 6 quartersCosmos Health Revenue ResultsActual Revenue$19.32 millionExpected Revenue$18.99 millionBeat/MissBeat by +$332.30 thousandYoY Revenue GrowthN/AUpcoming EarningsCosmos Health's next earnings date is estimated for Friday, November 13, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Cosmos Health Q2 2026 Earnings FAQ Did Cosmos Health beat earnings estimates for Q2 2026? Cosmos Health (NASDAQ:COSM) reported earnings of -$0.10 per share for Q2 2026, matching the consensus estimate of -$0.10. The report was announced on Tuesday, August 18, 2026. What was Cosmos Health's revenue for Q2 2026? Cosmos Health reported revenue of $19.32 million for Q2 2026, against a consensus estimate of $18.99 million. When is Cosmos Health's next earnings date? Cosmos Health's next earnings date is estimated for Friday, November 13, 2026. MarketBeat tracks confirmed and estimated earnings dates for Cosmos Health on the company's earnings history page. Cosmos Health Earnings HeadlinesComparing Amplifon (OTCMKTS:AMFPF) & Cosmos Health (NASDAQ:COSM)October 7 at 6:15 AM | americanbankingnews.comGuardant Health, Inc. Announces Cosmos-Mel01 Study Results for Guardant Reveal Liquid Biopsy Test in Resected MelanomaOctober 6 at 1:13 AM | marketscreener.comMDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.October 9 at 1:00 AM | Stansberry Research (Ad)Cosmos Health’s Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 BillionOctober 1, 2026 | usatoday.comCosmos Health’s CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 ...September 29, 2026 | usatoday.comCosmos Health climbs as CMO pipeline surpasses $20M in implied revenueSeptember 29, 2026 | seekingalpha.comSee More Cosmos Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cosmos Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cosmos Health and other key companies, straight to your email. Email Address About Cosmos HealthCosmos Health (NASDAQ:COSM) is a global healthcare group that develops, markets and distributes pharmaceutical, nutraceutical and wellness products. The company serves consumers, healthcare professionals and commercial partners through a portfolio that includes prescription and over-the-counter medicines, dietary supplements, vitamins and other health-related products. Cosmos Health markets proprietary nutraceutical brands, including Sky Premium Life, and offers products across categories such as vitamins, minerals, sports nutrition and general wellness. Through its pharmaceutical activities, the company is also involved in the wholesale distribution of medicines, medical products and related healthcare items. Founded in 2009 and formerly known as Cosmos Holdings Inc., the company is headquartered in Chicago and has operations and business relationships spanning the United States, Europe and other international markets. Its European activities have included pharmaceutical distribution and manufacturing partnerships, particularly in Greece. Cosmos Health is led by Chief Executive Officer Greg Siokos, who co-founded the company.View Cosmos Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Applied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt LoadJetBlue's LaGuardia Win Could Change Its Financial Future Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
